Is RAMM Pharma Corp halal to invest in?

According to Musaffa's Shariah screening methodology, RAMM Pharma Corp (RAMM.CN) is currently classified as DOUBTFUL as of June 2025. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is RAMM Pharma Corp a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes RAMM Pharma Corp using these criteria to determine its compliance status.

Can Muslims buy shares of RAMM Pharma Corp?

Muslim investors may consider investing in RAMM Pharma Corp if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is RAMM Pharma Corp classified as DOUBTFUL?

Musaffa determines the Shariah status of RAMM Pharma Corp by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for RAMM Pharma Corp updated?

The Shariah compliance status of RAMM Pharma Corp may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like RAMM Pharma Corp become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of RAMM Pharma Corp?

You can check the latest Shariah compliance status of RAMM Pharma Corp on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

RAMM.CN Shariah Compliance

Screening Methodology: AAOIFI

DOUBTFUL

Last Updated: June 27, 2025

Report Source: 2025 1st Quarter Report

RAMM Pharma Corp. Stock Analysis RAMM.CN

Canada Health Care Nano Cap Report: Q1, 2025

RAMM Pharma Corp. engages in the field of cannabinoid pharmacology and product formulation for cannabis-based pharmaceuticals and other cannabis-based products. The company is headquartered in Toronto, Ontario. The company went IPO on 2019-11-08. The company has multiple approved and registered products that have been authorized for sale, as well as other products in various stages of development. The firm also operates GMP certified cannabis formulation facilities in Uruguay and Poland to ensure their products are compliant with the standard and address international markets. The firm owns and operates a medical services business in Uruguay and a cosmetic and nutraceutical business in the European Union. The firm's brands include Medic Plast, Nettalife, Canapar, and Marishanti. Its subsidiaries include Medic Plast S.A., Yurelan S.A., RAMM Pharma Holdings Corp., Canapar Corp, and Hempoland S.p.a Z.o.o.

Key Statistics of RAMM Pharma Corp (RAMM.CN)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

CAD0.04CAD0.06

Today's Open

CAD0.02

Volume

3000.00

P/E Ratio (TTM)

52 Week Range

CAD0.01CAD0.25

Market Cap

1.79M

Avg. Volume

70.68K

Dividend Yield

Financial Metrics & Statements of RAMM Pharma Corp (RAMM.CN)

FAQ's for RAMM Pharma Corp (RAMM.CN)

According to Musaffa’s Shariah screening methodology, RAMM Pharma Corp (RAMM.CN) is currently classified as DOUBTFUL as of June 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.